The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2013 Jan 11

PMID 23304064

Citations 91

Authors

Tao Yu

Young-Su Yi

Yanyan Yang

Jueun Oh

Deok Jeong

Jae Youl Cho

Affiliations

Soon will be listed here.

Abstract

Inflammation is a complex biological response of tissues to harmful stimuli such as pathogens, cell damage, or irritants. Inflammation is considered to be a major cause of most chronic diseases, especially in more than 100 types of inflammatory diseases which include Alzheimer's disease, rheumatoid arthritis, asthma, atherosclerosis, Crohn's disease, colitis, dermatitis, hepatitis, and Parkinson's disease. Recently, an increasing number of studies have focused on inflammatory diseases. TBK1 is a serine/threonine-protein kinase which regulates antiviral defense, host-virus interaction, and immunity. It is ubiquitously expressed in mouse stomach, colon, thymus, and liver. Interestingly, high levels of active TBK1 have also been found to be associated with inflammatory diseases, indicating that TBK1 is closely related to inflammatory responses. Even though relatively few studies have addressed the functional roles of TBK1 relating to inflammation, this paper discusses some recent findings that support the critical role of TBK1 in inflammatory diseases and underlie the necessity of trials to develop useful remedies or therapeutics that target TBK1 for the treatment of inflammatory diseases.

Citing Articles

TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases.

Hui L, Chen X, Huang M, Jiang Y, Liu T Int J Mol Sci. 2025; 26(5).

PMID: 40076567 PMC: 11900955. DOI: 10.3390/ijms26051941.

Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.

Wang R, Dong X, Zhang X, Liao J, Cui W, Li W Int J Biol Sci. 2025; 21(3):958-973.

PMID: 39897033 PMC: 11781167. DOI: 10.7150/ijbs.103877.

Inhibition of IRF3-STING axis interaction in silicosis using natural compounds: an in-silico study using molecular docking, ADMET, molecular dynamics and MMPBSA approach.

Sood A, Kulharia M In Silico Pharmacol. 2024; 13(1):1.

PMID: 39659978 PMC: 11625707. DOI: 10.1007/s40203-024-00290-5.

Functional Involvement of TANK-Binding Kinase 1 in the MyD88-Dependent NF-B Pathway Through Syk.

Kim H, Kim J, Yu T, Cho J Mediators Inflamm. 2024; 2024:8634515.

PMID: 39493293 PMC: 11531359. DOI: 10.1155/2024/8634515.

In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery.

Ivanov J, Tenchov R, Ralhan K, Iyer K, Agarwal S, Zhou Q J Chem Inf Model. 2024; 64(19):7488-7502.

PMID: 39289178 PMC: 11480986. DOI: 10.1021/acs.jcim.4c00864.

References

Cocchi F, Devico A, Garzino-Demo A, Arya S, Gallo R, Lusso P . Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995; 270(5243):1811-5. DOI: 10.1126/science.270.5243.1811. View

Moret F, Badot V, Lauwerys B, van Roon J . Intraarticular soluble interleukin-7 [corrected] receptor levels are increased in patients with rheumatoid arthritis and correlate with local mediators of inflammation: comment on the article by Pickens et al. Arthritis Rheum. 2011; 64(2):594-5. DOI: 10.1002/art.33373. View

Harris J, Oliere S, Sharma S, Sun Q, Lin R, Hiscott J . Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J Immunol. 2006; 177(4):2527-35. DOI: 10.4049/jimmunol.177.4.2527. View

Lee Y, Lee J, Byeon S, Yoo D, Kim M, Lee S . Functional role of Akt in macrophage-mediated innate immunity. Front Biosci (Landmark Ed). 2011; 16(2):517-30. DOI: 10.2741/3702. View

Yu T, Lee J, Lee Y, Byeon S, Kim M, Sohn E . In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J Ethnopharmacol. 2010; 128(1):139-47. DOI: 10.1016/j.jep.2009.12.042. View

Cole K, Strick C, Paradis T, Ogborne K, Loetscher M, Gladue R . Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998; 187(12):2009-21. PMC: 2212354. DOI: 10.1084/jem.187.12.2009. View

Xie X, Zhang D, Zhao B, Lu M, You M, Condorelli G . IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc Natl Acad Sci U S A. 2011; 108(16):6474-9. PMC: 3081021. DOI: 10.1073/pnas.1016132108. View

Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A . The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 2008; 27(15):2135-46. PMC: 2453059. DOI: 10.1038/emboj.2008.126. View

Clement J, Meloche S, Servant M . The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 2009; 18(9):889-99. DOI: 10.1038/cr.2008.273. View

10.

Huang J, Liu T, Xu L, Chen D, Zhai Z, Shu H . SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways. EMBO J. 2005; 24(23):4018-28. PMC: 1356304. DOI: 10.1038/sj.emboj.7600863. View

11.

Pomerantz J, Baltimore D . NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 1999; 18(23):6694-704. PMC: 1171732. DOI: 10.1093/emboj/18.23.6694. View

12.

Youn H, Lee J, Saitoh S, Miyake K, Kang K, Choi Y . Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol. 2006; 72(7):850-9. DOI: 10.1016/j.bcp.2006.06.021. View

13.

Clark K, Plater L, Peggie M, Cohen P . Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem. 2009; 284(21):14136-46. PMC: 2682862. DOI: 10.1074/jbc.M109.000414. View

14.

Kim H, Lee S, Jung G . The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1. FEBS Lett. 2009; 584(3):525-30. DOI: 10.1016/j.febslet.2009.11.091. View

15.

Huang W, Chen W, Chen Y, Wang L, Hsu S, Chen C . Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells. J Cell Physiol. 2011; 227(4):1446-54. DOI: 10.1002/jcp.22860. View

16.

McIver E, Bryans J, Birchall K, Chugh J, Drake T, Lewis S . Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases. Bioorg Med Chem Lett. 2012; 22(23):7169-73. DOI: 10.1016/j.bmcl.2012.09.063. View

17.

Eiro N, Vizoso F . Inflammation and cancer. World J Gastrointest Surg. 2012; 4(3):62-72. PMC: 3332223. DOI: 10.4240/wjgs.v4.i3.62. View

18.

Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M . Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 2000; 19(18):4976-85. PMC: 314216. DOI: 10.1093/emboj/19.18.4976. View

19.

Qureshi N, Vogel S, Van Way 3rd C, Papasian C, Qureshi A, Morrison D . The proteasome: a central regulator of inflammation and macrophage function. Immunol Res. 2005; 31(3):243-60. DOI: 10.1385/IR:31:3:243. View

20.

Shen R, Hahn W . Emerging roles for the non-canonical IKKs in cancer. Oncogene. 2010; 30(6):631-41. PMC: 3235643. DOI: 10.1038/onc.2010.493. View